Login
$ONCY
$0.47 -$0.03 (5.79%) Close

$ONCY 4 SEC Filings

Filed On Filing
03 Jun 2026 Form 4: Pisano Wayne, Director

Granted 30,000 Stock Option

03 Jun 2026 Form 4: Rigby Jonathan, Director

Granted 30,000 Stock Option

03 Jun 2026 Form 4: Holtham Angela, Director

Granted 30,000 Stock Option

03 Jun 2026 Form 4: Parsons James T., Director

Granted 30,000 Stock Option

03 Jun 2026 Form 4: Look Kirk, Chief Financial Officer

Granted 260,000 Stock Option

03 Jun 2026 Form 4: Aromando Andrew, Chief Business Officer

Granted 260,000 Stock Option

03 Jun 2026 Form 4: Kelly Jared, Director

Granted 755,000 Stock Option

03 Jun 2026 Form 4: Andrews Patricia S, Director

Granted 30,000 Stock Option

03 Jun 2026 Form 4: Seizinger Bernd R., Director

Granted 30,000 Stock Option

03 Jun 2026 Form 4: Hagerman Allison, Chief Technology Officer

Granted 260,000 Stock Option

03 Jun 2026 Form 4: Brown Deborah Margaret, Director

Granted 30,000 Stock Option

03 Jun 2026 Form 4: Heineman Thomas Charles, Chief Medical Officer

Granted 260,000 Stock Option

03 Jun 2026 Form 4: McAdory John Bearden, Chief Operating Officer

Granted 145,000 Stock Option

03 Jun 2026 Form 4: Glover Stephen C., Director

Granted 96,000 Stock Option

13 Mar 2026 Form 4: Parsons James T., Director

Bought 10,000 shares ($10.3K)

13 Mar 2026 Form 4: Kelly Jared, Director

Bought 5,050 shares ($4.85K)

13 Feb 2026 Form 4: Look Kirk, Chief Financial Officer

Bought 12,000 shares ($10.1K)

13 Feb 2026 Form 4: Pisano Wayne, Director

Bought 30,000 shares ($25.3K)

13 Feb 2026 Form 4: Kelly Jared, Director

Bought 5,600 shares ($4.68K) · Bought 29,500 shares ($24.8K)

13 Feb 2026 Form 4: Heineman Thomas Charles, Chief Medical Officer

Bought 12,132 shares ($10K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support